Showing results (1-10 of 125) with videos related to
Sort By:
Pageof 13
Plos One|August 25, 2022
Mutations in the TERC template sequence can be incorporated into the telomeres of human tumorsRadwa Sharaf, Garrett M Frampton, Lee A AlbackerThe Oncologist|July 10, 2024
Understanding variants of unknown significance and classification of genomic alterationsDean C Pavlick, Garrett M Frampton, Jeffrey R RossGenomics|July 24, 2012
CpG island structure and trithorax/polycomb chromatin domains in human cellsDavid A Orlando, Matthew G Guenther, Garrett M Frampton, et al.Cancer Immunology Research|September 9, 2018
Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint BlockadeNatalie Galanina, Aaron M Goodman, Philip R Cohen, et al.Cancer Immunology Research|August 14, 2019
Microsatellite-Stable Tumors with High Mutational Burden Benefit from ImmunotherapyAaron M Goodman, Ethan S Sokol, Garrett M Frampton, et al.Genes & Development|November 4, 2009
SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell stateSteve Bilodeau, Michael H Kagey, Garrett M Frampton, et al.Cancer|September 12, 2018
GNAS, GNAQ, and GNA11 alterations in patients with diverse cancersAustin J Parish, Vi Nguyen, Aaron M Goodman, et al.Genome Medicine|March 1, 2022
A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeresRadwa Sharaf, Meagan Montesion, Julia F Hopkins, et al.The Journal of Molecular Diagnostics : JMD|February 1, 2005
Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arraysChialin King, Ning Guo, Garrett M Frampton, et al.Rare Tumors|December 21, 2016
Primary Intraosseous Smooth Muscle Tumor of Uncertain Malignant Potential: Original Report and Molecular CharacterizationLauren Kropp, Gene P Siegal, Garrett M Frampton, et al.Pageof 13